In search of the biological basis of mood disorders: Exploring out of the mainstream

Psychoneuroendocrinology

Volumn 36, Issue 3, 2011, Pages 305-307

  Branchi, Igor ^a   Schmidt, Mathias V ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; GLUCOCORTICOID; INDOLEAMINE 2,3 DIOXYGENASE; TRYPTOPHAN HYDROXYLASE 2;

ADULTHOOD; COPING BEHAVIOR; DEPRESSION; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; EDITORIAL; ENVIRONMENTAL FACTOR; EPIGENETICS; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; IMMUNOPATHOLOGY; LIFE STRESS; MOOD DISORDER; NEGATIVE FEEDBACK; NERVE CELL PLASTICITY; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SEROTONINERGIC TRANSMISSION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATIONAL RESEARCH;

BIOLOGICAL MARKERS; GLUCOCORTICOIDS; HUMANS; MOOD DISORDERS; PROGNOSIS; RESEARCH; SEROTONIN; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 79951953770     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2010.12.013     Document Type: Editorial

References (19)

1. Anacker, C., Zunszain, P.A., Carvalho, L.A., Pariante, C.M. The glucocorticoid receptor: pivot of depression and of antidepressant treatment? Psychoneuroendocrinology, in press.
2. Belmaker R.H., Agam G. Major depressive disorder. N. Engl. J. Med. 2008, 358:55-68.
3. Branchi, I. The double edged sword of neural plasticity: increasing serotonin levels leads to both greater vulnerability to depression and improved capacity to recover. Psychoneuroendocrinology, in press.
4. Cirulli, F., Reif, A., Herterich, S., Lesch, K.P., Berry, A., Francia, N., Aloe, L., Barr, C.S., Suomi, S., Alleva, E. A novel BDNF polymorphism affects plasma protein levels in interaction with early adversity in rhesus macaques, in press.
5. Cryan J.F., Slattery D.A. Animal models of mood disorders: recent developments. Curr. Opin. Psychiatry 2007, 20:1-7.
6. Curley, J.P., Jensen, C.L., Mashoodh, R., Champagne, F.A. Social influences on neurobiology and behavior: epigenetic effects during development. Psychoneuroendocrinology, in press.
7. Dantzer, R., O'Connor, J.C., Lawson, M.A., Kelley, K.W. Inflammation-association depression: from serotonin to kynurenine, in press.
8. Harro, J., Kiive, E. Droplets of black bile? Development of vulnerability and resilience to depression in young age. Psychoneuroendocrinology, in press.
9. Heim C., Shugart M., Craighead W.E., Nemeroff C.B. Neurobiological and psychiatric consequences of child abuse and neglect. Dev. Psychobiol. 2010, 52:671-690.
10. Holsboer F. How can we realize the promise of personalized antidepressant medicines? Nat. Rev. Neurosci. 2008, 9:638-646.
11. Joels, M. Impact of glucocorticoids on brain function: relevance for mood disorders. Psychoneuroendocrinology, in press.
12. Kato M., Serretti A. Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder. Mol. Psychiatry 2010, 15:473-500.
13. Macri S., Wurbel H. Developmental plasticity of HPA and fear responses in rats: a critical review of the maternal mediation hypothesis. Horm. Behav. 2006, 50:667-680.
14. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat. Neurosci. 2010, 13:1161-1169.
15. Pryce, C.R., Seifritz, E. A translational research framework for enhanced validity of mouse models of psychopathological states in depression. Psychoneuroendocrinology, in press.
16. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
17. Schmidt, M.V. Animal models for depression and the mismatch hypothesis of disease. Psychoneuroendocrinology, in press.
18. Suomi S.J. Risk, resilience, and gene×environment interactions in rhesus monkeys. Ann. N. Y. Acad. Sci. 2006, 1094:52-62.
19. Waider, J., Naozumi, A., Gutknecht, L., Lesch, K.P. Tryptophan hydroxylase-2 (TPH2) in disorders of emotion regulation including depression and ADHD, in press.